The benchmarking and application of tag-degraders in vivo to validate therapeutic targets

Journal:

Nature Communications

Published:

2026-05-29

DOI:

10.1038/s41467-026-73681-1

Affiliations:

9

Authors:

17

Go to article

Institutions	Authors	Share
Walter and Eliza Hall Institute of Medical Research (WEHI), Australia	8.083333	0.48
The University of Melbourne (UniMelb), Australia	5.666667	0.33
Promega, United States of America (USA)	1.000000	0.06
University of Dundee, United Kingdom (UK)	1.000000	0.06
Olivia Newton-John Cancer Research Institute (ONJCRI), Australia	0.500000	0.03
La Trobe University, Australia	0.500000	0.03
Royal Melbourne Hospital (RMH), Australia	0.250000	0.01

Interested in Pharmacology and Pharmaceutical Sciences?